· Summary
· PCA principles
· PC
· PK
· PD
|
Morphine |
Fentanyl |
Settings |
1mg q5min |
20mcg q5min |
Onset |
Slower |
Faster |
Offset |
Slower |
Faster |
Intra-op loading dose |
Not needed |
Needed |
Side effects |
More |
Less |
Suitable patient |
Young, large, athletic |
Older, OSA, risk of sedation |
Definition |
· User controlled, locked, IV analgesic pump · Usually opioid |
Indication |
· High opioid requirement · Unreliable gut function · Risk of overdose (OSA, OHS, severe COPD, sedated) |
Toxicity |
· Respiratory depression · Sedation · Airway obstruction · Death |
· Both stable in solution
· Both unlikely to precipitate with other drugs
Time course:
Parameter |
Morphine |
Fentanyl |
Time to peak effect |
30 mins |
5 mins |
Bolus duration |
2-3 hours |
5-20 mins |
->Morphine provides longer-lasting pain relief, but dose stacking may
occur
->Fentanyl is better suited to q5min protocol
Distribution:
Parameter |
Morphine |
Fentanyl |
Lipid solubility |
1x |
600x |
pKa |
8 |
8.4 |
% unionized |
23% |
9% |
t1/2ke0 |
17 min |
7 min |
% plasma protein bound |
35% |
83% |
VD (L/kg) |
3.5 |
4 |
Elimination:
Parameter |
Morphine |
Fentanyl |
Speed -Cl (mL/kg/min) -t1/2b (mins) -Extraction ratio |
16 170 0.76 |
13 210 0.8 |
Metabolism |
Liver: phase 2>1 (Glucuronidation) |
Liver: phase 1>2 (CYP3A4) |
Metabolites |
M6G analgesic M3G neurotoxic |
Inactive |
Excretion |
Renal: parent and metabolites |
Renal: metabolites only |
->Similar offset time after saturation
->Fentanyl safer in renal failure ± liver failure
Parameter |
Morphine |
Fentanyl |
Receptors M/K/D |
3:1:1 |
3:1:0 |
PONV |
↑ |
↓ |
Histamine release |
↑ |
↓ |
Confusion |
↑ |
↓ |
Abuse potential |
↓ |
↑ (faster onset) |
Feedback welcome at ketaminenightmares@gmail.com